Oslo, 31 May 2022: Reference is made to the stock exchange announcement published earlier today, on 31 May 2022 by Navamedic ASA (the "Company" or "Navamedic"), regarding the board of directors' resolution to increase the Company's share capital with NOK 55,500 by the issuance of 75,000 new shares, in order to facilitate the settlement of exercise of 75,000 share options in the Company.

Primary insider, Lars Hjarrand, CFO of Navamedic, has today, on 31 May 2022, exercised 75,000 share options in the Company under his option agreements from 2019 and 2020, respectively, and subscribed for 75,000 new shares in the Company following such option exercise. Following the option exercise and subscription of the new shares, Lars Hjarrand holds 260,882 shares and 75,000 options in the Company.

Please refer to the attached notification of trading for further details.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.